We are live on ! Find out more
Lord, Abbett & Co

Lord, Abbett & Co Portfolio holdings

AUM $30.6B
1-Year Est. Return 57.44%
This Fund
S&P 500
This Quarter Est. Return
+11.47%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$44.9B
AUM Growth
+$1.51B
Cap. Flow
-$3.93B
Cap. Flow %
-8.75%
Top 10 Hldgs %
9.25%
Holding
1,161
New
143
Increased
326
Reduced
483
Closed
121

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$163M
2
HRI icon
Herc Holdings
HRI
+$160M
3
VYX icon
NCR Voyix
VYX
+$155M
4
APTV icon
Aptiv
APTV
+$147M
5
XLNX
Xilinx Inc
XLNX
+$141M

Sector Composition

Rank Sector Weight
1 Financials 18.3%
2 Industrials 13.62%
3 Healthcare 11.97%
4 Energy 8.91%
5 Consumer Discretionary 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEE icon
676
Ameren
AEE
$31.1B
$7.24M 0.02%
200,300
-700
-0.3% -$25.1K
SCHW
677
Charles Schwab
SCHW
$184B
$7.24M 0.02%
278,590
+158,022
+131% +$3.77M
AGO icon
678
Assured Guaranty
AGO
$3.79B
$7.22M 0.02%
306,000
+230,300
+304% +$5.01M
MPWR icon
679
Monolithic Power Systems
MPWR
$63B
$7.18M 0.02%
207,086
+12,452
+6% +$398K
FN icon
680
Fabrinet
FN
$16.1B
$7.17M 0.02%
+348,664
New +$6.45M
DGX icon
681
Quest Diagnostics
DGX
$26B
$7.16M 0.02%
+133,800
New +$7.94M
X
682
DELISTED
US Steel
X
$7.15M 0.02%
242,243
-33,598
-12% -$866K
RPTP
683
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$7.08M 0.02%
543,775
-178,074
-25% -$2.45M
CSII
684
DELISTED
Cardiovascular Systems, Inc.
CSII
$7.07M 0.02%
+206,150
New +$6M
SPXC icon
685
SPX Corp
SPXC
$10.2B
$7.04M 0.02%
280,484
-1,743
-0.6% -$40.1K
TSS
686
DELISTED
Total System Services, Inc.
TSS
$6.99M 0.02%
210,100
+45,800
+28% +$1.41M
TWTR
687
DELISTED
Twitter, Inc.
TWTR
$6.94M 0.02%
+109,023
New +$5.41M
GNTX icon
688
Gentex
GNTX
$5.12B
$6.92M 0.02%
+419,510
New +$6.15M
CPLA
689
DELISTED
Capella Education Company
CPLA
$6.88M 0.02%
+103,489
New +$6.47M
ALXN
690
DELISTED
Alexion Pharmaceuticals
ALXN
$6.88M 0.02%
+51,668
New +$6.2M
APEI icon
691
American Public Education
APEI
$917M
$6.82M 0.02%
+156,799
New +$6.47M
NVDQ
692
DELISTED
Novadaq Technologies Inc.
NVDQ
$6.79M 0.02%
411,468
+150,108
+57% +$2.49M
VRSK icon
693
Verisk Analytics
VRSK
$27.8B
$6.74M 0.02%
102,535
+64,516
+170% +$4.24M
RMD icon
694
ResMed
RMD
$30.3B
$6.69M 0.01%
+142,139
New +$7.19M
BRCM
695
DELISTED
BROADCOM CORP CL-A
BRCM
$6.66M 0.01%
224,500
-318,097
-59% -$8.66M
CHEF icon
696
Chefs' Warehouse
CHEF
$4.09B
$6.64M 0.01%
227,809
+51,306
+29% +$1.28M
AR icon
697
Antero Resources
AR
$10.5B
$6.64M 0.01%
+104,700
New +$5.86M
POWL icon
698
Powell Industries
POWL
$7.32B
$6.63M 0.01%
296,868
-68,058
-19% -$1.47M
DAL icon
699
Delta Air Lines
DAL
$58.8B
$6.61M 0.01%
+240,746
New +$6.47M
DRC
700
DELISTED
DRESSER-RAND GROUP INC
DRC
$6.56M 0.01%
+110,000
New +$6.52M

Similar funds

Lord, Abbett & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Lord, Abbett & Co held 1,161 positions worth $44.9B, up 3.5% from $43.4B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Lord, Abbett & Co withdrew a net $3.93B in Q4 2013, closing 121 positions and reducing 483 holdings. Its most notable exit was Labcorp, an estimated $163M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Lord, Abbett & Co opened a new position in American Airlines Group worth $129M.

  • Lord, Abbett & Co's largest Q4 2013 buy was American Airlines Group: 5,122,124 shares worth $129M.
  • Lord, Abbett & Co added most to Gilead Sciences in Q4 2013, an estimated $241M increase.
  • Lord, Abbett & Co's biggest Q4 2013 reduction was Herc Holdings, cutting an estimated $160M.
  • Lord, Abbett & Co fully exited Labcorp in Q4 2013, selling an estimated $163M.
  • Lord, Abbett & Co's ten largest holdings make up 9.3% of its $44.9B portfolio in Q4 2013.
  • Lord, Abbett & Co opened 143 new positions and closed 121 in Q4 2013.
  • Lord, Abbett & Co's portfolio value rose 3.5% quarter-over-quarter to $44.9B.

Based on Lord, Abbett & Co's 13F filing for Q4 2013, filed 14 Feb 2014.